On Thursday ElectroCore (NASDAQ: ECOR) fell 3.14% to $1.54 on rocketing demand for the daily volume of 22,289,976 shares while the average volume is only 4,161,075 shares.
Meanwhile being popular for GammaCore device ElectroCore tries searching for other health-related technology to increase revenue and earnings as well. Many biotech and healthcare corporations do not even have earnings when they fully depend on issuing shares, releasing bonds, and taking debts.
Today ECOR doubles on uncertain volume which can be clear aftermarket at 09-00 AM EDT. Other healthcare stocks are increasing as well making investors hesitate in picking alternatives. Being alert at stock news may lead to quick profits. Notifications could be useful anytime.